StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$30.78+1.10 (+3.71%)

Close on Nov 19, 2026Market cap $1.03BP/E –Yield –

SpyGlass Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for SpyGlass Pharma

SpyGlass Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More SpyGlass Pharma figures

See a number that looks wrong?